Rock Point Advisors, LLC Pfizer Inc Transaction History

Rock Point Advisors, LLC

$356 Million
Q3 2025

A detailed history of Rock Point Advisors, LLC transactions in Pfizer Inc stock. As of the latest transaction made, Rock Point Advisors, LLC holds 123,667 shares of PFE stock, worth $3.1 Million. This represents 0.89% of its overall portfolio holdings.

Number of Shares

123,667

Previous 94,009 31.55%

Holding current value

$3.1 Million

Previous $2.28 Million 38.32%

% of portfolio

0.89%

Previous 0.68%

32 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 12, 2025	BUY	$23.29 - $25.88 $690,734 - $767,549	29,658 Added 31.55%	123,667 $3.15 Million
Q2 2025 Aug 14, 2025	BUY	$21.59 - $24.84 $47,865 - $55,070	2,217 Added 2.42%	94,009 $2.28 Million
Q1 2025 Apr 30, 2025	BUY	$25.01 - $27.13 $29,761 - $32,284	1,190 Added 1.31%	91,792 $2.33 Million
Q4 2024 Feb 13, 2025	SELL	$24.8 - $30.19 $28,966 - $35,261	-1,168 Reduced 1.27%	90,602 $2.4 Million
Q3 2024 Nov 13, 2024	BUY	$27.7 - $31.39 $9,972 - $11,300	360 Added 0.39%	91,770 $2.66 Million

Q2 2024 Aug 08, 2024	SELL	$25.26 - $29.6 $21,294 - $24,952	-843 Reduced 0.91%	91,410 $2.56 Million
Q1 2024 May 10, 2024	BUY	$25.89 - $29.73 $325,566 - $373,854	12,575 Added 15.78%	92,253 $2.56 Million
Q4 2023 Feb 08, 2024	SELL	$26.13 - $33.94 $136,842 - $177,743	-5,237 Reduced 6.17%	79,678 $2.29 Million
Q3 2023 Nov 09, 2023	BUY	$32.09 - $37.51 $238,974 - $279,336	7,447 Added 9.61%	84,915 $2.82 Million
Q2 2023 Aug 10, 2023	BUY	$36.12 - $41.79 $76,213 - $88,176	2,110 Added 2.8%	77,468 $2.84 Million
Q1 2023 May 10, 2023	BUY	$39.39 - $51.28 $171,661 - $223,478	4,358 Added 6.14%	75,358 $3.08 Million
Q4 2022 Feb 09, 2023	SELL	$41.75 - $54.5 $51,686 - $67,471	-1,238 Reduced 1.71%	71,000 $3.64 Million
Q3 2022 Nov 10, 2022	SELL	$43.76 - $53.42 $27,962 - $34,135	-639 Reduced 0.88%	72,238 $3.16 Million
Q2 2022 Aug 10, 2022	SELL	$46.53 - $55.17 $476,094 - $564,499	-10,232 Reduced 12.31%	72,877 $3.82 Million
Q1 2022 May 10, 2022	SELL	$45.75 - $56.69 $316,498 - $392,181	-6,918 Reduced 7.68%	83,109 $4.3 Million
Q4 2021 Feb 09, 2022	SELL	$41.32 - $61.25 $78,921 - $116,987	-1,910 Reduced 2.08%	90,027 $5.32 Million
Q3 2021 Nov 05, 2021	SELL	$39.25 - $50.42 $181,374 - $232,990	-4,621 Reduced 4.79%	91,937 $3.95 Million
Q2 2021 Aug 05, 2021	SELL	$35.91 - $40.68 $241,243 - $273,288	-6,718 Reduced 6.5%	96,558 $3.78 Million
Q1 2021 May 12, 2021	BUY	$33.49 - $37.77 $675,560 - $761,896	20,172 Added 24.27%	103,276 $3.74 Million
Q4 2020 Feb 08, 2021	BUY	$33.47 - $42.56 $2.33 Million - $2.96 Million	69,500 Added 510.88%	83,104 $3.06 Million
Q3 2020 Nov 10, 2020	SELL	$31.75 - $37.25 $84,613 - $99,271	-2,665 Reduced 16.38%	13,604 $499,000
Q2 2020 Aug 12, 2020	SELL	$30.12 - $36.54 $10,542 - $12,789	-350 Reduced 2.11%	16,269 $532,000
Q4 2019 Feb 06, 2020	SELL	$32.92 - $37.36 $823 - $934	-25 Reduced 0.15%	16,619 $651,000
Q3 2019 Nov 08, 2019	BUY	$32.49 - $42.13 $5,133 - $6,656	158 Added 0.96%	16,644 $598,000
Q2 2019 Aug 12, 2019	SELL	$36.98 - $41.52 $21,448 - $24,081	-580 Reduced 3.4%	16,486 $714,000
Q1 2019 May 08, 2019	SELL	$37.5 - $41.2 $75,000 - $82,400	-2,000 Reduced 10.49%	17,066 $725,000
Q4 2018 Jan 31, 2019	SELL	$38.47 - $43.86 $3,847 - $4,386	-100 Reduced 0.52%	19,066 $832,000
Q3 2018 Nov 07, 2018	SELL	$34.47 - $41.81 $54,290 - $65,850	-1,575 Reduced 7.59%	19,166 $845,000
Q2 2018 Aug 09, 2018	BUY	$32.98 - $35.16 $8,080 - $8,614	245 Added 1.2%	20,741 $752,000
Q1 2018 May 11, 2018	SELL	$31.91 - $37.02 $10,849 - $12,586	-340 Reduced 1.63%	20,496 $727,000
Q4 2017 Feb 09, 2018	SELL	$33.26 - $35.29 $23,049 - $24,455	-693 Reduced 3.22%	20,836 $755,000
Q3 2017 Nov 03, 2017	BUY	$31.0 - $34.15 $667,399 - $735,215	21,529	21,529 $769,000

Others Institutions Holding PFE

# of Institutions

3,358

Shares Held

3.57B

Call Options Held

86.1M

Put Options Held

105M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $141B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Rock Point Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Rock Point Advisors, LLC with notifications on news.

Account

Rock Point Advisors, LLC Pfizer Inc Transaction History